V Planelles

Author PubWeight™ 40.47‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The human immunodeficiency virus type 1 vpr gene arrests infected T cells in the G2 + M phase of the cell cycle. J Virol 1995 4.42
2 High-efficiency gene transfer into CD34+ cells with a human immunodeficiency virus type 1-based retroviral vector pseudotyped with vesicular stomatitis virus envelope glycoprotein G. J Virol 1996 2.57
3 Requirement of human immunodeficiency virus type 1 nef for in vivo replication and pathogenicity. J Virol 1994 2.45
4 Genetic analysis of human immunodeficiency virus type 1 integrase and the U3 att site: unusual phenotype of mutants in the zinc finger-like domain. J Virol 1995 2.22
5 Genetic and biological comparisons of pathogenic and nonpathogenic molecular clones of simian immunodeficiency virus (SIVmac). AIDS Res Hum Retroviruses 1992 1.92
6 Immune response of rhesus macaques to recombinant simian immunodeficiency virus gp130 does not protect from challenge infection. J Virol 1993 1.68
7 Apoptosis in AIDS. Apoptosis 2001 1.31
8 Coreceptor utilization by human immunodeficiency virus type 1 is not a primary determinant of neutralization sensitivity. J Virol 1998 1.28
9 Human T-cell leukemia viruses: epidemiology, biology, and pathogenesis. Blood Rev 1997 1.22
10 Comparison of cell cycle arrest, transactivation, and apoptosis induced by the simian immunodeficiency virus SIVagm and human immunodeficiency virus type 1 vpr genes. J Virol 2001 1.21
11 ATR and GADD45alpha mediate HIV-1 Vpr-induced apoptosis. Cell Death Differ 2005 1.19
12 Lentivirus vectors using human and simian immunodeficiency virus elements. J Virol 1999 1.15
13 Primary isolate neutralization by HIV type 1-infected patient sera in the era of highly active antiretroviral therapy. AIDS Res Hum Retroviruses 1999 1.12
14 CD26 antigen and HIV fusion? Science 1994 1.05
15 Defective lentiviral vectors are efficiently trafficked by HIV-1 and inhibit its replication. Mol Ther 2001 1.03
16 Upregulation of survivin by HIV-1 Vpr. Apoptosis 2003 1.02
17 Roles of p53 and caspases in the induction of cell cycle arrest and apoptosis by HIV-1 vpr. Exp Cell Res 1999 0.99
18 Mutation of the methylated tRNA(Lys)(3) residue A58 disrupts reverse transcription and inhibits replication of human immunodeficiency virus type 1. J Virol 2001 0.97
19 Multigene lentiviral vectors based on differential splicing and translational control. Mol Ther 2001 0.96
20 Inhibition of HIV-1 replication using a mutated tRNALys-3 primer. J Biol Chem 1997 0.95
21 HTLV type 1 Tax transduction in microglial cells and astrocytes by lentiviral vectors. AIDS Res Hum Retroviruses 2000 0.89
22 Inhibition of HIV type 1 infection with a RANTES-IgG3 fusion protein. AIDS Res Hum Retroviruses 1998 0.87
23 [Epidemiology and burden of acute otitis media in Valencia (Spain)]. An Pediatr (Barc) 2004 0.86
24 Characterization of group specific antibodies in primates: studies with SIV envelope in macaques. J Med Primatol 1992 0.85
25 Lentiviral vectors and gene therapy. Front Biosci 1999 0.84
26 Efficient gene transfer into human monocyte-derived macrophages using defective lentiviral vectors. Cell Mol Biol (Noisy-le-grand) 2003 0.84
27 Eradication of pre-established lymphoma using herpes simplex virus amplicon vectors. Blood 1999 0.83
28 Characterization of rhesus macaque B-lymphoblastoid cell lines infected with simian type D retrovirus. AIDS Res Hum Retroviruses 1991 0.80
29 Development of an Rev-independent, minimal simian immunodeficiency virus-derived vector system. Hum Gene Ther 2001 0.77
30 Induction of cell-cycle arrest in cervical cancer cells by the human immunodeficiency virus type 1 viral protein R. Obstet Gynecol 2000 0.76
31 A RANTES-antibody fusion protein retains antigen specificity and chemokine function. J Immunol 1998 0.76
32 Lentivirus and foamy virus vectors: novel gene therapy tools. Expert Opin Biol Ther 2001 0.75
33 SIV and FIV vaccine studies at UC Davis: 1991 update. AIDS Res Hum Retroviruses 1992 0.75